Abstract:Introduction: miR-146a is one of the first identified miRNAs expressed differentially in osteoarthritis (OA) cartilage. However, the role it plays in OA pathogenesis is not clear. The aim of this study is to identify a molecular target of miR-146a, thereby elucidating its function in chondrocytes during OA pathogenesis.Methods: Primary chondrocytes from Sprague-Dawley rats were treated with IL-1 beta before the expression levels of miR-146a, Smad4 and vascular endothelial growth factor (VEGF) were quantified by real-time PCR and/or western blotting. The effect of miR-146a on cellular response to transforming growth factor (TGF)-beta 1 was quantified by a luciferase reporter harboring TGF-beta 1 responsive elements and by extracellular signal-regulated kinase assay. The effect of miR-146a on apoptosis was quantified by the TUNEL assay. OA pathogenesis was surgically induced with joint instability in rats, evaluated by histopathological analysis with safranin O staining, and the expression levels of miR-146a, Smad4, and VEGF were quantified using real-time PCR and/or immunohistochemistry.Results: IL-1 beta treatment of chondrocytes increased the expression levels of miR-146a and VEGF and decreased the levels of Smad4 in a time-dependent manner. miR-146a upregulated VEGF expression and downregulated Smad4 expression in chondrocytes, while a miR-146a inhibitor acted in a converse manner. Smad4, a common mediator of the TGF-beta pathway, is identified as a direct target of miR-146a by harboring a miR-146a binding sequence in the 3'-UTR region of its mRNA. Mutation of the binding sequence significantly relieved the inhibition of the Smad4 reporter activity by miR-146a. Furthermore, miR-146a upregulation of VEGF is mediated by Smad4. Expression of miR-146a led to a reduction of cellular responsiveness to TGF-beta and an increase of apoptosis rate in chondrocytes. In vivo, cartilage from surgically induced OA rats displayed higher levels of miR-146a and VEGF compared with the sham group. In contrast, Smad4 expression level was lower in the OA group than the sham group.Conclusion: IL-1 beta responsive miR-146a is overexpressed in an experimentally induced OA model, accompanied by upregulation of VEGF and downregulation of Smad4 in vivo. miR-146a may contribute to OA pathogenesis by increasing VEGF levels and by impairing the TGF-beta signaling pathway through targeted inhibition of Smad4 in cartilage.

miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4

Mir-146a, An Il-1 Beta Responsive Mirna, Induces Vascular Endothelial Growth Factor And Chondrocyte Apoptosis By Targeting Smad4

Silencing miR-146a-5p Protects against Injury-Induced Osteoarthritis in Mice

Mir-146B Accelerates Osteoarthritis Progression by Targeting Alpha-2-macroglobulin

Mir-146A Facilitates Osteoarthritis by Regulating Cartilage Homeostasis Via Targeting Camk2d and Ppp3r2.

MiR-146a-5p promotes IL-1β-induced chondrocyte apoptosis through the TRAF6-mediated NF-kB pathway

MicroRNA-15a/β1,4-GalT-I Axis Contributes to Cartilage Degeneration Via NF-κB Signaling in Osteoarthritis

Microrna-34a Affects Chondrocyte Apoptosis And Proliferation By Targeting The Sirt1/P53 Signaling Pathway During The Pathogenesis Of Osteoarthritis

MiR-15a-5p Regulates Viability and Matrix Degradation of Human Osteoarthritis Chondrocytes Via Targeting VEGFA.

Role of MiR-146a in Cartilage Repair in Osteoarthritis of the First Metatarsophalangeal Joint by Influencing the TGF- β1/Smads Signaling Pathway

MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway.

MicroRNA-410-3p modulates chondrocyte apoptosis and inflammation by targeting high mobility group box 1 (HMGB1) in an osteoarthritis mouse model

Mir-210-3p Protects Against Osteoarthritis Through Inhibiting Subchondral Angiogenesis by Targeting the Expression of TGFBR1 and ID4

Mir-93-5p Attenuates IL-1β-induced Chondrocyte Apoptosis and Cartilage Degradation in Osteoarthritis Partially by Targeting TCF4

MiR146a modulates chondrogenesis of bone marrow mesenchymal stem cells by modulating Lsm11 expression.

MicroRNA-140 Suppresses Human Chondrocytes Hypertrophy by Targeting SMAD1 and Controlling the Bone Morphogenetic Protein Pathway in Osteoarthritis.

The Mir-302C/transforming Growth Factor-Β Receptor Type-2 Axis Modulates Interleukin-1Β-induced Degenerative Changes in Osteoarthritic Chondrocytes

Inhibition of Microrna-495 Suppresses Chondrocyte Apoptosis Through Activation of the NF-κB Signaling Pathway by Regulating CCL4 in Osteoarthritis

MicroRNA‑186‑5p Downregulation Inhibits Osteoarthritis Development by Targeting MAPK1.

miR-590-5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting FGF18 in osteoarthritis

MicroRNA-145 attenuates TNF-α-driven cartilage matrix degradation in osteoarthritis via direct suppression of MKK4